Dr. Asma Bibi | Clinical Laboratory Consultant in Chennai | Rela Institute, India

Dr. Asma Bibi

MBBS, MD, HBNI FELLOWSHIP

Consultant

Clinical Laboratory

Chennai

Brief Profile

Pathology training done at JIPMER with completion of my thesis entitled “Histopathological and immunohistochemical evaluation of follicular patterned neoplasms of thyroid” for the partial fulfillment of the degree of M.D. (BRANCH-III) Pathology during the year 2010 - 2013. I started my senior residency at JIPMER where I carried out teaching the undergraduates and post graduates students of Pathology. Further, I pursued my Senior Residency followed by two years fellowship in Haematopathology in Tata Memorial Hospital, Mumbai.

Special Training:

Completed 2 years of HBNI fellowship in the Haematopathology laboratory, Tata Memorial Hospital. The Hematopathology Laboratory at Tata memorial Hospital had given the signatory authority to me which in turn was accredited by the National Accreditation Board for testing and calibration laboratories (NABL). It provided comprehensive hematology training for hemato-lymphoid malignancies like Leukaemia, Lymphoma and Multiple Myeloma diagnosis with exposure in state of art facilities like flow cytometry for diagnosis and minimal residual disease monitoring in acute leukaemia. I have been trained in the laboratory to provide reliable, accurate and timely diagnostic services to all our patients and referring clinicians. The laboratory had a large workload and processed an average of 700 hemograms and 300 coagulation samples per day. The laboratory also received 7000 bone marrow aspiration samples annually. This laboratory also analysed 5000 flow cytometry samples in a year. These include assays for immunophenotyping of hematolymphoid malignancies (leukemia and lymphoma), CD34 stem cell enumeration for bone marrow transplants, molecular testing. I have been trained in reporting of bone marrow aspirate, peripheral smears, body fluid cytospin smears, flow cytometry immunophenotyping including analysis and reporting of minimal residual disease. I have received 4 months of molecular haematopathology training which includes diagnosing the various molecular abnormalities in chronic myeloproliferative neoplasm, chronic lymphoproliferative disorder, molecular monitoring of chronic myeloid leukaemia and acute promyelocytic leukaemia. In addition, I have received training in histopathology reporting of lymphoreticular system for a period of 4 months. I have also been to cytogenetic reporting in acute leukaemia under Dr Pratibha Amare for a period of one month as a part of my peripheral posting in fellowship. As a part of our fellowship training I have participated in the multidisciplinary joint clinics for newly diagnosed cases of various haematolymphoid neoplasms. I had been to Department of Transfusion Medicine & Immunohaematology, Christian Medical College, Vellore from 1st April 2016 to 30th April 2016 as a visitor observer in the areas of coagulation, clinical haematology, peripheral and bone marrow aspirate smear reporting.

Educational Qualifications

  • MBBS - 2008, Jawaharlal Institute of Post graduate Medical Education and Research JIPMER, Pondicherry, India
  • MD - 2013, Jawaharlal Institute of Post graduate Medical Education and Research JIPMER, Pondicherry, India
  • HBNI FELLOWSHIP - 2016, IN HAEMATOPATHOLOGY Haemato-patholog Laboratory, Tata Memorial Hospital, Mumbai, India

Clinical Expertise

  • Trained in Flow cytometry and molecular pathology.
  • Diagnostic and Minimal residual disease detection by flow cytometry in hematolymphoid neoplasms.
  • (Acute leukaemia, Chronic lymphoproliferative disorders, Multiple Myeloma, Lymphoma, Primary Immune deficiency work up by flow cytometry, Immunological assays by flow cytometry)
  • Certified internal auditor by FQI.

Experience

Experience: Post MD 5 and half years

  • I have worked as Consultant in Pathology Department of Cancer Institute Adyar, Chennai and have reported peripheral smears, bone marrow aspirate smears, cytochemistry, bone marrow biopsies and flow cytomteric immunophenotyping, immunohistochemistry on trephine biopsies in haematolymphoid neoplasms. I have participated in the medical oncology weekly forum as a part of cases being discussed.
  • I have worked an Associate Consultant in Haematopathology Department of Apollo Cancer Institute, Teynampet. I have independently reported the peripheral smears, bone marrow aspirate smears, cytospin from body fluids, cytochemistry, immunophenotyping which includes diagnosis of acute leukaemia, chronic lymphoproliferative disorder, minimal residual disease reporting in B ALL, T ALL, AML, CLL and MM. I have reported cases of myeloma, CD20 monitoring post rituximab therapy, CD34 enumeration, T and B cell subsets.

Accomplishments

Talk Delivered:

  1. Participated as Faculty in the “Third CME for Medical Laboratory Technologists” conducted at Tata Memorial Hospital, Mumbai on 21st & 22nd December 2013.
  2. Participated as Faculty in the Eleventh Clinical Cytometry Course conducted at Tata Memorial Hospital and Super Religare Labs Ltd, Mumbai, from 17th to 21st February 2014.
  3. Participated as Faculty in the Twelfth Clinical Cytometry Course conducted at Tata Memorial Hospital and Super Religare Labs Ltd, Mumbai, from 4th to 8st August 2014.
  4. Delivered a lecture in the Post conference Workshop conducted on November 9, 2014, “T and T/NK cell lymphomas” at Apollo Hospital, Hyderabad.
  5. Participated as Faculty in the “Fourth CME for Medical Laboratory Technologists” conducted at Tata Memorial Hospital, Mumbai on 21st & 22nd December 2014.
  6. Participated as Faculty in the “Fifth CME for Medical Laboratory Technologists” conducted at Tata Memorial Hospital, Mumbai on 19th & 20th December 2015.
  7. Participated as Faculty in the “Sixth CME for Medical Laboratory Technologists” to be held in Tata Memorial Hospital, Mumbai on 21th & 22nd December 2016.

Honors & Awards

  1. First prize at the Annual TAPCON 2010 quiz competition organized by the Department of Pathology, JIPMER on the 13th and 14th August 2010.
  2. Third prize in the Pathology quiz competition organized during PATHMEET 2012, held at Indira Gandhi Medical College & Research Institute (IGMC & RI), Pondicherry on 11th February 2012.
  3. First Prize at the 8th Annual Meeting of the cytometry society held on 24th-25th October 2015 for oral paper titled “New immunophenotypic markers in B cell acute lymphoblastic leukemia in minimal residual disease detection”.
  4. Attended AMP 2015 Annual Meeting and Exhibits- November 5th -7th 2015, Austin, Texas and presented a poster on “Copy number alterations in Precursor B lineage acute lymphoblastic leukemia”.

Affiliations And Memberships

Lifetime Member of The Cytometry Society of India

Research & Publication

  1. Siddhartha Das, Bhawana Badhe, Asma Bibi and Manoj K. Mohanty. Sudden Death as a Complication of Choriocarcinoma. J Forensic Sci, January 2015, Vol. 60, No. 1 doi: 10.1111/1556-4029.12581
  2. Asma Bibi, PG Subramanian, Satish Mirgal, Karishma Chopra, Shruti Chaudhary, Swapnali Joshi, Sheetal Garware, Prashant Tembhare, Sumeet Gujral, Nikhil Patkar. Acute lymphoblastic leukemia: IKAROS gene deletions in precursor B lineage acute lymphoblastic leukemia (B-ALL). Agarwal MB, editor. Hematology update. Mumbai Hematology Group, Mumbai, pp 331-338.
  3. Kiran Ghodke, Asma Bibi, Nikhil Rabade, Nikhil Patkar, PG Subramanian, Pratibha Kadam Aamre, Y Badrinath , Sitram Ghogale, Sumeet Gujral and Prashant Tembhare. CD19 Negative Precursor B Acute Lymphoblastic Leukemia (B-ALL) - immunophenotypic challenges in diagnosis and monitoring: A study of three cases. Cytometry B Clin Cytom. 2016 Mar 28. doi: 10.1002/cyto.b.21373.
  4. Prashant Tembhare, Sitaram Ghogale S, Nisha , Y Badrinath , Nikesh Kunder , Nikhil Patkar, Asma Bibi, Gaurav Chatterjee, Brijesh Arora, Gaurav Narula, S Banawali , Nilesh Deshpande, Pratibha Kadam Amare, Sumeet Gujral, PG Subramanian. Evaluation of new markers for minimal residual disease monitoring in B-cell precursor acute lymphoblastic leukemia: CD73 and CD86 are the most relevant new markers to increase the efficacy of MRD assay. Cytometry B Clin Cytom. 2016 Oct 7. doi: 10.1002/cyto.b.21486. [Epub ahead of print]
  5. Rabade N, Bibi A, Ghodke K, Tembhare P, Amare P, Subramanian P G, Gujral S. Lymphoblastic leukemia with surface light chain restriction: A diagnostic dilemma. Indian j Pathol Microbiol 2016; 59: 410-2
  6. Nikhil Patkar, PG Subramanian, Prashant Tembhare, Sneha Mandalia, Gaurav Chaterjee, Nikhil Rabade, Rohan Kodgule, Karishma Chopra, Asma Bibi, Swapnali Joshi, Shruti Chaudhary, Russel Mascerhenas, Pratibha Kadam-Amare, Gaurav Narula, Brijesh Arora, Shripad Banavali, Sumeet Gujral. An integrated genomic profile that includes copy number alterations is highly predictive of minimal residual disease status in childhood precursor B-lineage acute lymphoblastic leukemia. Indian J Pathol Microbiol. 2017 April-June, Volume 60. Issue 2.
  7. Bibi A, Java S, Chaudhary S, Joshi S, Mascerhenas R, Rabade N, Tembhare P, Subramanian PG, Gujral S, Menon H, Khattry N, Sengar M, Bagal B, Jain H, Patkar N. BRAFV600E mutation in hairy cell leukemia: A single-center experience. Indian J Pathol Microbiol [serial online] 2018 [cited 2019 Jul 1];61: 532-6. Available from: http://www.ijpmonline.org/text.asp?2018/61/4/532/242988

To seek a quick appointment

Copyrights © 2021 Rela Institute & Medical Centre. All Rights Reserved.